Cargando...

Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

Hydroxychloroquine, used to treat malaria and some autoimmune disorders, potently inhibits viral infection of SARS coronavirus (SARS-CoV-1) and SARS-CoV-2 in cell-culture studies. However, human clinical trials of hydroxychloroquine failed to establish its usefulness as treatment for COVID-19. This...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS Pathog
Main Authors: Ou, Tianling, Mou, Huihui, Zhang, Lizhou, Ojha, Amrita, Choe, Hyeryun, Farzan, Michael
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7845965/
https://ncbi.nlm.nih.gov/pubmed/33465165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1009212
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!